Delivery Order SPE2DB24D2101-SPE2DB24FKFBB

Award Date 7/3/24
Potential Completion Date 7/25/24
Potential Value $27K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is for the supply of Opdivo 240 mg/24 ml vials to the U.S. government. The $11,471.10 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA, which serves as the primary vehicle for the...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 240 mg/24 ml vials of the medication Opdivo. The contract has a ceiling value of $16,297.52 and is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $78,951.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,813.58 fixed-price contract is for the delivery of 240 mg/24 ml vials of the medication Opdivo. The contract has an ultimate completion date of June 12, 2025 and is not a set-aside award. Amerisourcebergen Drug Corp is also the prime contractor on a larger $999,999,999.00 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of Opdivo 240mg/24ml vial medication to the U.S. government. The $74,849.40 firm-fixed-price Delivery Order contract has a completion date of June 11, 2024 and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DOD). Amerisourcebergen holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $15,294.80 firm fixed price delivery order is for the supply of 24 ml vials of the pharmaceutical product Opdivo. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $77,575.80, is for the delivery of 240 mg/24 ml vials of the medication Opdivo. The award is a delivery order under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 and running through November 2026. This IDC serves as the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,782.51 firm fixed-price delivery order is for OPDIVO 240 MG/24 ML VIAL 24ML and has an ultimate completion date of April 11, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 that serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $47,370.96 for the pharmaceutical product Opdivo 240 mg/24 ml vial. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,955.85 firm fixed-price delivery order covers the supply of 240 mg/24 ml vials of the cancer medication Opdivo. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKFBB
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $26,765.90, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to support the DLA's mission of providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The specific contract award is for the delivery of 240 mg/24 ml vials of Opdivo, a prescription drug. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.

Generated 10/2/24, 10:40 AM